References
- Ahern, T. P., Hertz, D. L., Damkier, P., Ejlertsen, B., Hamilton-Dutoit, S. J., Rae, J. M., Regan, M. M., Thompson, A. M., Lash, T. L., & Cronin-Fenton, D. P. (2017). Cytochrome P-450 2D6 (CYP2D6) genotype and breast cancer recurrence in tamoxifen-treated patients: Evaluating the importance of loss of heterozygosity. American Journal of Epidemiology, 185(2), 75–85. https://doi.org/https://doi.org/10.1093/aje/kww178
- Ahmad, I. (2016). Recent insight into the biological activities of synthetic xanthone derivatives. European Journal of Medicinal Chemistry, 116, 267–280. https://doi.org/https://doi.org/10.1016/j.ejmech.2016.03.058
- Aisha, A. F., Abu-Salah, K. M., Ismail, Z., & Majid, A. M. S. A. (2012). α-Mangostin enhances betulinic acid cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells. Molecules (Basel, Switzerland), 17(3), 2939–2954. https://doi.org/https://doi.org/10.3390/molecules17032939
- Ames, B. N., Gurney, E., Miller, J. A., & Bartsch, H. (1972). Carcinogens as frameshift mutagens: Metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proceedings of the National Academy of Sciences, 69(11), 3128–3132. https://doi.org/https://doi.org/10.1073/pnas.69.11.3128
- Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/https://doi.org/10.1002/jcc.20290
- Castillo-Garit, J. A., Marrero-Ponce, Y., Torrens, F., & García-Domenech, R. (2008). Estimation of ADME properties in drug discovery: Predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices. Journal of Pharmaceutical Sciences, 97(5), 1946–1976. https://doi.org/https://doi.org/10.1002/jps.21122
- Crew, K. D., Albain, K. S., Hershman, D. L., Unger, J. M., & Lo, S. S. (2017). How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ Breast Cancer, 3(1), 1–7. https://doi.org/https://doi.org/10.1038/s41523-017-0021-y
- Damkier, P., Kjaersgaard, A., Barker, K. A., Cronin-Fenton, D., Crawford, A., Hellberg, Y., Janssen, E. A. M., Langefeld, C., Ahern, T. P., & Lash, T. L. (2017). CYP2C19* 2 and CYP2C19* 17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the international tamoxifen pharmacogenomics consortium dataset. Scientific Reports, 7, 7727.
- DeSantis, C. E., Fedewa, S. A., Goding Sauer, A., Kramer, J. L., Smith, R. A., & Jemal, A. (2016). Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: A Cancer Journal for Clinicians, 66(1), 31–42. https://doi.org/https://doi.org/10.3322/caac.21320
- Ganoth, A., Merimi, K. C., & Peer, D. (2015). Overcoming multidrug resistance with nanomedicines. Expert Opinion on Drug Delivery, 12(2), 223–238. https://doi.org/https://doi.org/10.1517/17425247.2015.960920
- Ghasemzadeh, A., Jaafar, H. Z., Baghdadi, A., & Tayebi-Meigooni, A. (2018). Alpha-mangostin-rich extracts from mangosteen pericarp: Optimization of green extraction protocol and evaluation of biological activity. Molecules, 23(8), 1852.
- Gu, Y., Chen, T., Li, G., Xu, C., Xu, Z., Zhang, J., He, K., Zheng, L., Guan, Z., Su, X., Cao, J., & Teng, L. (2017). Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer. Oncotarget, 8(32), 52156–52177. https://doi.org/https://doi.org/10.18632/oncotarget.11044
- Gutierrez-Orozco, F., Chitchumroonchokchai, C., Lesinski, G. B., Suksamrarn, S., & Failla, M. L. (2013). α-Mangostin: Anti-inflammatory activity and metabolism by human cells. Journal of Agricultural and Food Chemistry, 61(16), 3891–3900. https://doi.org/https://doi.org/10.1021/jf4004434
- Hultsch, S., Kankainen, M., Paavolainen, L., Kovanen, R.-M., Ikonen, E., Kangaspeska, S., Pietiäinen, V., & Kallioniemi, O. (2018). Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer, 18(1), 850. https://doi.org/https://doi.org/10.1186/s12885-018-4757-z
- Katzenellenbogen, J. A., Mayne, C. G., Katzenellenbogen, B. S., Greene, G. L., & Chandarlapaty, S. (2018). Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nature Reviews Cancer, 18(6), 377–388. https://doi.org/https://doi.org/10.1038/s41568-018-0001-z
- Keen, P. (1971). Effect of binding to plasma proteins on the distribution, activity and elimination of drugs. In Concepts in biochemical pharmacology (pp. 213–233). Springer.
- Khan, P., Queen, A., Mohammad, T., Smita, Khan, N. S., Hafeez, Z. B., Hassan, M., & Ali, S. (2019). Identification of α-Mangostin as a potential inhibitor of microtubule affinity regulating kinase 4. Journal of Natural Products, 82(8), 2252–2261. https://doi.org/https://doi.org/10.1021/acs.jnatprod.9b00372
- Kirchmair, J., Distinto, S., Markt, P., Schuster, D., Spitzer, G. M., Liedl, K. R., & Wolber, G. (2009). How to optimize shape-based virtual screening: Choosing the right query and including chemical information. Journal of Chemical Information and Modeling, 49(3), 678–692. https://doi.org/https://doi.org/10.1021/ci8004226
- Kurose, H., Shibata, M.-A., Iinuma, M., & Otsuki, Y. (2012). Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-mangostin extracted from mangosteen pericarp. BioMed Research International, 2012, 1–9.
- Lee, H. N., Jang, H. Y., Kim, H. J., Shin, S. A., Choo, G. S., Park, Y. S., Kim, S. K., & Jung, J. Y. (2016). Antitumor and apoptosis-inducing effects of α-mangostin extracted from the pericarp of the mangosteen fruit (Garcinia mangostana L.)in YD-15 tongue mucoepidermoid carcinoma cells. International Journal of Molecular Medicine, 37(4), 939–948. https://doi.org/https://doi.org/10.3892/ijmm.2016.2517
- Lee, S., Lee, I., Kim, H., Chang, G., Chung, J., & No, K. (2003). The PreADME approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. EuroQSAR Designing Drugs and Crop Protectants: Processes, Problems and Solutions (pp. 418–420). Blackwell.
- Li, P., Tian, W., & Ma, X. (2014). Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Molecular Cancer, 13(1), 138. https://doi.org/https://doi.org/10.1186/1476-4598-13-138
- Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016). Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians, 66(4), 271–289. https://doi.org/https://doi.org/10.3322/caac.21349
- Moiseenko, F., Volkov, N., Bogdanov, A., Dubina, M., & Moiseyenko, V. (2017). Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion. F1000Research, 6, 288.
- Moongkarndi, P., Kosem, N., Luanratana, O., Jongsomboonkusol, S., & Pongpan, N. (2004). Antiproliferative activity of Thai medicinal plant extracts on human breast adenocarcinoma cell line. Fitoterapia, 75(3–4), 375–377. https://doi.org/https://doi.org/10.1016/j.fitote.2004.01.010
- Morelli, C. F., Biagiotti, M., Pappalardo, V. M., Rabuffetti, M., & Speranza, G. (2015). Chemistry of α-mangostin. Studies on the semisynthesis of minor xanthones from Garcinia mangostana. Natural Product Research, 29(8), 750–755. https://doi.org/https://doi.org/10.1080/14786419.2014.986729
- Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand‐receptor docking. Current Protocols in Bioinformatics, 24(1), 8.14.11–18.14.40. https://doi.org/https://doi.org/10.1002/0471250953.bi0814s24
- Muchtaridi, M., Puteri, N. A., Milanda, T., & Musfiroh, I. (2017). Validation analysis methods of α-mangostin, ϒ-mangostin and gartanin mixture in mangosteen (Garcinia mangostana L.) fruit rind extract from west java with HPLC. Journal of Applied Pharmaceutical Science, 7(10), 125–130.
- Muchtaridi, M., Syahidah, H. N., Subarnas, A., Yusuf, M., Bryant, S. D., & Langer, T. (2017). Molecular docking and 3D-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha. Pharmaceuticals, 10(4), 81. https://doi.org/https://doi.org/10.3390/ph10040081
- Muchtaridi, M., & Wijaya, C. A. (2017). Anticancer potential of α-mangostin. Asian Journal of Pharmaceutical and Clinical Research, 10(12), 440. https://doi.org/https://doi.org/10.22159/ajpcr.2017.v10i12.20812
- Muchtaridi, M., Yusuf, M., Diantini, A., Choi, S. B., Al-Najjar, B. O., Manurung, J. V., Subarnas, A., Achmad, T. H., Wardhani, S. R., & Wahab, H. A. (2014). Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies. International Journal of Molecular Sciences, 15(5), 7225–7249. https://doi.org/https://doi.org/10.3390/ijms15057225
- Muchtaridi, M., Yusuf, M., Syahidah, H. N., Subarnas, A., Zamri, A., Bryant, S. D., & Langer, T. (2019). Cytotoxicity of chalcone of Eugenia aquea Burm F. leaves against T47D breast cancer cell lines and its prediction as an estrogen receptor antagonist based on pharmacophore-molecular dynamics simulation. Advances and Applications in Bioinformatics and Chemistry, 12, 33–43. https://doi.org/https://doi.org/10.2147/AABC.S217205
- Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. https://doi.org/https://doi.org/10.1021/jm300687e
- Narasimhan, S., Maheshwaran, S., Abu-Yousef, I. A., Majdalawieh, A. F., Rethavathi, J., Das, P. E., & Poltronieri, P. (2017). Anti-bacterial and anti-fungal activity of xanthones obtained via semi-synthetic modification of α-mangostin from Garcinia mangostana. Molecules, 22(2), 275. https://doi.org/https://doi.org/10.3390/molecules22020275
- Puratchikody, A., Sriram, D., Umamaheswari, A., & Irfan, N. (2016). 3D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment. Chemistry Central Journal, 10(1), 1–19. https://doi.org/https://doi.org/10.1186/s13065-016-0169-9
- Ruswanto, R., Mardianingrum, R., Siswandono, S., & Kesuma, D. (2020). Reverse docking, molecular docking, absorption, distribution, and toxicity prediction of artemisinin as an anti-diabetic candidate. Molekul, 15(2), 88–96. https://doi.org/https://doi.org/10.20884/1.jm.2020.15.2.579
- Sack, J. S., Gao, M., Kiefer, S. E., Myers, J. E., Newitt, J. A., Wu, S., & Yan, C. (2016). Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor. Acta Crystallographica Section F: Structural Biology Communications, 72(2), 129–134.
- Setiawati, A. (2014). Anticancer activity of mangosteen pericarp dry extract against MCF-7 breast cancer cell line through estrogen receptor-α. Indonesian Journal of Pharmacy, 25(3), 119.
- Shan, T., Ma, Q., Guo, K., Liu, J., Li, W., Wang, F., & Wu, E. (2011). Xanthones from mangosteen extracts as natural chemopreventive agents: Potential anticancer drugs. Current Molecular Medicine, 11(8), 666–677. https://doi.org/https://doi.org/10.2174/156652411797536679
- Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell, 95(7), 927–937. https://doi.org/https://doi.org/10.1016/S0092-8674(00)81717-1
- Simpson, C. D., Anyiwe, K., & Schimmer, A. D. (2008). Anoikis resistance and tumor metastasis. Cancer Letters, 272(2), 177–185. https://doi.org/https://doi.org/10.1016/j.canlet.2008.05.029
- Wang, C., Greene, D. A., Xiao, L., Qi, R., & Luo, R. (2017). Recent developments and applications of the MMPBSA method. Frontiers in Molecular Biosciences, 4, 87. https://doi.org/https://doi.org/10.3389/fmolb.2017.00087
- Wang, Q., Gun, M., & Hong, X-y. (2019). Induced tamoxifen resistance is mediated by increased methylation of e-cadherin in estrogen receptor-expressing breast cancer cells. Scientific Reports, 9(1), 1–7.
- WHO. (2019). World health statistics overview 2019: monitoring health for the SDGs, sustainable development goals [Internet]. World Health Organization. [citado 23 Abr 2019].
- Wieder, M., Perricone, U., Boresch, S., Seidel, T., & Langer, T. (2016). Evaluating the stability of pharmacophore features using molecular dynamics simulations. Biochemical and Biophysical Research Communications, 470(3), 685–689. https://doi.org/https://doi.org/10.1016/j.bbrc.2016.01.081
- Wieder, M., Perricone, U., Seidel, T., & Langer, T. (2016). Pharmacophore models derived from molecular dynamics simulations of protein–ligand complexes: A case study. Natural Product Communications, 11(10), 1499-1504.
- Wolber, G., & Langer, T. (2005). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160–169. https://doi.org/https://doi.org/10.1021/ci049885e
- Yan, A., Wang, Z., & Cai, Z. (2008). Prediction of human intestinal absorption by GA feature selection and support vector machine regression. International Journal of Molecular Sciences, 9(10), 1961–1976. https://doi.org/https://doi.org/10.3390/ijms9101961
- Yazdanian, M., Glynn, S. L., Wright, J. L., & Hawi, A. (1998). Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharmaceutical Research, 15(9), 1490–1494. https://doi.org/https://doi.org/10.1023/a:1011930411574
- Zhao, Y., Tang, G., Tang, Q., Zhang, J., Hou, Y., Cai, E., Liu, S., Lei, D., Zhang, L., & Wang, S. (2016). A method of effectively improved α-mangostin bioavailability. European Journal of Drug Metabolism and Pharmacokinetics, 41(5), 605–613. https://doi.org/https://doi.org/10.1007/s13318-015-0283-4
- Zheng, Q., Xu, F., Nie, M., Xia, W., Qin, T., Qin, G., An, X., Xue, C., Peng, R., Yuan, Z., Shi, Y., & Wang, S. (2015). Selective estrogen receptor modulator-associated nonalcoholic fatty liver disease improved survival in patients with breast cancer: A retrospective cohort analysis. Medicine, 94(40), e1718.